Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Schizophrenia Age: Adult Condition: Initial |
Dose: Oral – 10-15 mg Frequency: once daily Note: Dose increment should not be made before 2 weeks, the time needed to achieve steady state. |
|
Indication: Schizophrenia Age: Adult Condition: Maintenance |
Dose: Oral – 15 mg Frequency: once daily Note: Maximum: 30 mg once daily without regard to food. Dose increment should not be made before 2 weeks, the time needed to achieve steady state. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Schizophrenia Age: 13-17 years |
Dose: Oral – 2 mg/day Note: Initial dose. |
|
Indication: Schizophrenia Age: 13-17 years |
Dose: Oral – 5 mg/day Note: Increased after 2 days. |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Glomerular filtration rate between 15 and 90 mL/minute |
Dose: Aripiprazole Note: No dosage adjustment is required on the basis of a patient's renal function |
Administration
- Take with or without food
- Take at same time daily
Side Effect
- Weight gain (8-30%)
- Headache (27%)
- Agitation (19%)
- Insomnia (18%)
- Anxiety (17%)
- Nausea and vomiting (11-15%)
- Akathisia (10-13%)
- Lightheadedness (11%)
- Constipation (10-11%)
- Dizziness (10%)
- Dyspepsia (9%)
- Somnolence (5-8%)
- Fatigue (6%)
- Restlessness (6%)
- Tremor (6%)
- Dry mouth/xerostomia (5%)
- Extrapyramidal disorder (5%)
- Orthostatic hypotension (1-5%)
- Musculoskeletal stiffness (4%)
- Abdominal discomfort (3%)
- Blurred vision (3%)
- Cough (3%)
- Pain (3%)
- Myalgia (2%)
- Rash
- Rhinitis
- Altered mental status
- Autonomic instability
- Dysphagia
- Hyperpyrexia
- Muscle rigidity
- Neuroleptic malignant syndrome (NMS)
- Seizure
- Tardive dyskinesia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Carbamazepine
|
Could cause an increase in aripiprazole clearance and lower blood levels
|
|
Ketoconazole, Quinidine, Fluoxetine, Paroxetine
|
Can inhibit aripiprazole elimination and cause increased blood levels
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30°C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.